The Rapalogue, CCI-779, improves salivary gland function following radiation.
The Rapalogue, CCI-779, improves salivary gland function following radiation.
复制标题
DOI:
10.1371/journal.pone.0113183
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Limesand KH
中科院分区:
文献类型:
--
作者:
Morgan-Bathke M;Harris ZI;Arnett DG;Klein RR;Burd R;Ann DK;Limesand KH
The standard of care for head and neck cancer typically includes surgical resection of the tumor followed by targeted head and neck radiation. However depending on tumor location and stage, some cases may not require surgical resection while others may be treated with chemoradiation. Unfortunately, these radiation treatments cause chronic negative side effects for patients. These side effects are associated with damage to surrounding normal salivary gland tissue and include xerostomia, changes in taste and malnutrition. The underlying mechanisms of chronic radiation-induced salivary gland dysfunction are unknown, however, in rodent models persistently elevated proliferation is correlated with reduced stimulated salivary flow. The rapalogue, CCI-779, has been used in other cell systems to induce autophagy and reduce proliferation, therefore the aim of this study was to determine if CCI-779 could be utilized to ameliorate chronic radiation-induced salivary gland dysfunction. Four to six week old Atg5f/f; Aqp5-Cre, Atg5+/+; Aqp5-Cre and FVB mice were treated with targeted head and neck radiation. FVB mice were treated with CCI-779, chloroquine, or DMSO post-radiation. Stimulated salivary flow rates were determined and parotid and submandibular salivary gland tissues were collected for analyses. Mice with a defect in autophagy, via a conditional knockout of Atg5 in the salivary glands, display increased compensatory proliferation in the acinar cell compartment and hypertrophy at 24-72 hours following radiation. FVB mice treated with post-therapy CCI-779 have significant improvements in salivary gland physiology as determined by stimulated salivary flow rates, proliferation indices and amylase production and secretion. Consequently, post-radiation use of CCI-779 allows for improvement of salivary gland function and reestablishment of glandular homeostasis. As CCI-779 is already FDA approved for other uses, it could have a secondary use to alleviate the chronic side effects in head and neck cancer patients who have completed anti-tumor therapy.
登录
查看更多内容
影响因子:
5.7
作者:
Blanchard, Pierre;Baujat, Bertrand;Pignon, Jean-Pierre
通讯作者:
Pignon, Jean-Pierre
影响因子:
1.1
作者:
Cady, Jormain
通讯作者:
Cady, Jormain
影响因子:
4.8
作者:
Henson, BS;Eisbruch, A;Ship, JA
通讯作者:
Ship, JA
DOI:
10.5500/wjt.v4.i2.133
发表时间:
2014-06-24
期刊:
World journal of transplantation
影响因子:
--
作者:
Fernandez-Yunquera, Ainhoa;Ripoll, Cristina;Salcedo, Magdalena
通讯作者:
Salcedo, Magdalena
影响因子:
3.8
作者:
Grundmann O;Fillinger JL;Victory KR;Burd R;Limesand KH
通讯作者:
Limesand KH